Robust behavioral assessment of the inducible Friedreich's ataxia mouse does not show improvement with NRF2 induction
Open Access
- 1 March 2025
- journal article
- Published by The Company of Biologists in Disease Models & Mechanisms
- Vol. 18 (3)
Abstract
Friedreich's ataxia, a recessive disorder caused by a mutation in the frataxin (FXN) gene, has few mouse models that demonstrate a progressive behavioral decline paralleling that of patients. A mouse model of systemic frataxin deficiency, the FXNKD, was recently developed using a doxycycline-inducible method; it is thought to mimic the patient phenotype seen when frataxin levels are decreased, but it has not been determined whether it is reliable for assessment of therapeutics. FXNKD mice underwent testing for 12 weeks alongside littermates, undergoing tests of motor function, gait and sensation. Additionally, a subset underwent treatment with omaveloxolone or dimethyl fumarate, both NRF2 inducers. We identified multiple techniques that sensitively detect decline in the mice, including open field, gait analysis and Von Frey tests. Furthermore, we developed a novel Salinas–Montgomery ataxia scale, which allows for more comprehensive assessment than a four-part cerebellar ataxia scale. Despite validating multiple sensitive techniques, we did not see any benefits of NRF2-inducing therapies in any tests. This was exacerbated by the discovery of a sexual dimorphism in FXNKD mice, in which males show more significant decline and better responsiveness to NRF2-inducing therapeutics.Keywords
Funding Information
- NIH Office of the Director (R01HL155907)
- Friedreich's Ataxia Research Alliance
- National Institutes of Health (R01HL155907, R33NS106719)
- Foundation for the National Institutes of Health (T32 HL086350)
- University of California, Davis
This publication has 39 references indexed in Scilit:
- Pathology and pathogenesis of sensory neuropathy in Friedreich’s ataxiaActa Neuropathologica, 2010
- Dose translation from animal to human studies revisitedThe FASEB Journal, 2007
- GAA repeat expansion mutation mouse models of Friedreich ataxia exhibit oxidative stress leading to progressive neuronal and cardiac pathologyGenomics, 2006
- Friedreich’s ataxiaPediatric Neurology, 2003
- Frataxin knockin mouseFEBS Letters, 2002
- Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron depositsNature Genetics, 2001
- Inactivation of the Friedreich ataxia mouse gene leads to early embryonic lethality without iron accumulationHuman Molecular Genetics, 2000
- Friedreich ataxia: an overviewJournal of Medical Genetics, 2000
- Friedreich's Ataxia: Autosomal Recessive Disease Caused by an Intronic GAA Triplet Repeat ExpansionScience, 1996
- Tactile extinction: Distinguishing between sensorimotor and motor asymmetries in rats with unilateral nigrostriatal damagePharmacology Biochemistry and Behavior, 1982